Mountain Capital Investment Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,976
Closed -$1.16M 104
2021
Q4
$1.16M Buy
5,976
+1,438
+32% +$301K 0.52% 68
2021
Q3
$857K Sell
4,538
-255
-5% -$46.5K 0.45% 81
2021
Q2
$864K Sell
4,793
-813
-15% -$140K 0.4% 79
2021
Q1
$998K Buy
5,606
+1,170
+26% +$179K 0.5% 76
2020
Q4
$634K Buy
+4,436
New +$559K 0.38% 90

Other funds holding MEDP

Mountain Capital Investment Advisors's MEDP Position: Q1 2022 in Review

Mountain Capital Investment Advisors sold out of Medpace (MEDP) in Q1 2022, closing a stake of 5,976 shares — an estimated $1.16M sold.

Mountain Capital Investment Advisors first reported a position in MEDP in Q4 2020 and held it in 5 quarters. The position peaked at $1.16M in Q4 2021. 349 funds tracked by Wall St. Rank hold MEDP as of Q1 2022.

  • Mountain Capital Investment Advisors reported no remaining Medpace position as of Q1 2022 after selling out during the quarter.
  • Mountain Capital Investment Advisors sold 5,976 Medpace shares in Q1 2022, an estimated $1.16M.
  • Mountain Capital Investment Advisors first reported a position in Medpace in Q4 2020 and held it in 5 quarters.
  • Mountain Capital Investment Advisors's Medpace position peaked at $1.16M in Q4 2021.
  • 349 funds tracked by Wall St. Rank held Medpace as of Q1 2022.

Based on Mountain Capital Investment Advisors's 13F filing for Q1 2022, filed 12 Apr 2022.